Research at Â鶹ÍøÕ¾The following technologies are currently available for licensing through Queen's Partnerships and innovation. If you'd like to learn more about these innovations and/or explore partnership, please reach out to our office by emailing qpi.info@queensu.ca.
Optically Tracked Navigated Biopsy Capsule for Precision Brain Tumor Sampling
Antagonists of Apoptosis Inducing Factor-1, Mitochondrial (AIFM1) for Anticoronaviral Therapy
Advanced FISH-Based Assay for PTEN and Tumor Suppressor Gene Deletion Detection
Minimally Invasive Ventriculo- peritoneal Shunt System for Simplifying Hydrocephalus Treatment
Orally Delivered Protein Treatment Protects Against Clostridioides Difficile Infection
Antagonists of Dynamin-related Protein-1 (drp1) for Pulmonary Arterial Hypertension
Precision Deparaffinization for Sample Analysis and Preservation
Non-Invasive Intraocular Pressure Monitoring Soft Contact Lens
DNA Methylation-Based Liquid Biopsy for Monitoring of Metastatic Triple-Negative Breast Cancer (mTNBC)
Diagnosing Cognitive Impairment After COVID-19 Infection
Treatment for Reducing Respiratory Distress in COVID-19 Patients
Novel Signal Processing Technique for Atrial Fibrillation
Hippo Pathway Bioluminescent Biosensor
Investigating the Role of Retinoic Acid Metabolizing Bacteria in Dysregulating the Microgut Biome in Favor of Pathogenic Species
A Concise Approach to the Synthesis of SERCA Inhibitor Thapsigargin
Novel Treatment for Rheumatoid Arthritis
Novel CYP26A1-Selective Inhibitors
Complex Arrythmia Activation Mapping without a Time Alignment Reference
Machine Learning Approach for Diagnosing Long QT Syndrome
MMP-14 Antibodies as Novel Therapeutics for Metastatic Cancers
Novel Fluorescence EEM Spectroscopy Method
Localized Delivery of Drugs/Biologics that are Susceptible to Degradation in Acidic Environments
Novel Treatment for Glioblastoma
